| < Case Report> A case of “a left middle lobe of lung” with a left superior vena cava in a patient who underwent lung cancer surgery T Takemoto, T Mitsudomi, Y Tsutani ACTA MEDICA KINDAI UNIVERSITY 47 (2), 49-52, 2022 | | 2022 |
| 1079 A phase II trial of chemoradiotherapy followed by surgery in pancoast tumors: Initial report of the Japan Clinical Oncology Group trial (JCOG 9806) Y Ichinose, H Kunitoh, H Kato, N Ishizuka, R Tsuchiya, M Tsuboi, ... EJC Supplements 5 (1), S323, 2003 | 1 | 2003 |
| 124P Phase II study of neoadjuvant concurrent chemo-immuno-radiation therapy followed by surgery and adjuvant immunotherapy for resectable stage IIIA-B N2 non-small cell lung … T Miyoshi, A Hamada, J Soh, A Hata, K Nakamatsu, M Shimokawa, ... Immuno-Oncology and Technology 16, 2022 | | 2022 |
| 1261O Neoadjuvant nivolumab (N)+ ipilimumab (I) vs chemotherapy (C) in the phase III CheckMate 816 trial MM Awad, PM Forde, N Girard, JD Spicer, C Wang, S Lu, T Mitsudomi, ... Annals of Oncology 34, S731, 2023 | 13 | 2023 |
| 134O_PR: Plasma ctDNA analysis for detection of EGFR T790M mutation in patients (pts) with EGFR mutation-positive advanced non-small cell lung cancer (aNSCLC) S Jenkins, J Yang, S Ramalingam, K Yu, S Patel, S Weston, R Lawrance, ... Journal of Thoracic Oncology 11 (4), S153-S154, 2016 | 16 | 2016 |
| 3 to 5 manuscripts P Adusumilli, J Aerts, D Aisner, R Alfieri, K Aokage, H Asamura, C Azzoli, ... Journal of Thoracic Oncology 11 (3), 271-273, 0 | | |
| 3016 Receptor tyrosine kinase mutations in non-small cell lung cancer H Hayashi, Y Togashi, M Terashima, K Sakai, H Mizuuchi, Y Kobayashi, ... European Journal of Cancer 3 (51), S601, 2015 | | 2015 |
| 3046 Impact of bevacizumab in combination with erlotinib on EGFRmutatant non-small cell lung cancer xenograft models with T790M mutation or MET amplification K Furugaki, J Fukumura, T Iwai, K Yorozu, M Yanagisawa, Y Moriya, ... European Journal of Cancer 3 (51), S611-S612, 2015 | 1 | 2015 |
| 3083 AZD9291 activity in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC) and brain metastases: data from phase II studies MJ Ahn, CM Tsai, JCH Yang, FA Shepherd, M Satouchi, DW Kim, ... European Journal of Cancer 3 (51), S625-S626, 2015 | 54 | 2015 |
| 39IN BEYOND EGFR, KRAS, ALK; WHAT ELSE? T Mitsudomi Lung Cancer, S23, 2011 | | 2011 |
| 3rd European Lung Cancer Conference Officers B Passlick, R Dziadziuszko, C Faivre-Finn, C Gridelli, RA Stahel, ... | | |
| 72PD LOBECTOMY IN COMBINATION WITH RADICAL LYMPHADENECTOMY IS THE MOST FREQUENT SURGICAL INTERVENTION PERFORMED IN PATIENTS RANDOMIZED IN MAGRIT TRIAL EVALUATING MAGE-A3 … M Zielinski, J Zo, T Vanakesa, J Dahabreh, H Hoffmann, M Holzer, ... Lung Cancer, S37-S38, 2011 | | 2011 |
| 84O Neoadjuvant nivolumab (N)+ platinum-doublet chemotherapy (C) for resectable NSCLC: 3-y update from CheckMate 816 PM Forde, J Spicer, N Girard, M Provencio, S Lu, C Wang, M Awad, ... Journal of Thoracic Oncology 18 (4), S89-S90, 2023 | 35 | 2023 |
| 9002 A phase III, first-line trial of gefitinib versus cisplatin plusdocetaxel for patients with advanced or recurrent non-small cell lungcancer (NSCLC) harboring activating … J Tsurutani, T Mitsudomi, S Mori, I Okamoto, N Kaname, H Tada, ... EJC Supplements 2 (7), 505, 2009 | 14 | 2009 |
| 9008 ORAL Randomized Phase III Trial of Adjuvant Chemotherapy With Gemcitabine Compared With Oral Tegafur-uracil (UFT) in Resected, Stage IB-llla Non-small Cell Lung Cancer … T Mitsudomi, H Tada, Y Ichinose, K Yokoi, N Katakami, M Oda, S Negoro, ... European Journal of Cancer, S594, 2011 | 1 | 2011 |
| 931MO Final overall survival analysis of phase III study of pemetrexed/cisplatin versus vinorelbine/cisplatin for completely resected non-squamous non-small cell lung cancer … K Yoh, H Kenmotsu, N Yamamoto, T Misumi, T Takahashi, H Saito, ... Annals of Oncology 33, S972-S973, 2022 | | 2022 |
| 932MO Nivolumab (NIVO) plus platinum-doublet chemotherapy (chemo) versus chemo as neoadjuvant treatment for resectable non-small cell lung cancer (NSCLC): health-related … E Felip, C Wang, TE Ciuleanu, G Saylors, F Tanaka, KN Chen, H Ito, ... Annals of Oncology 33, S973-S974, 2022 | 4 | 2022 |
| A 25-signal proteomic signature and outcome for patients with resected non–small-cell lung cancer K Yanagisawa, S Tomida, Y Shimada, Y Yatabe, T Mitsudomi, ... Journal of the National Cancer Institute 99 (11), 858-867, 2007 | 101 | 2007 |
| A carcinoma arising from benign pleomorphic adenoma of the trachea S Mori, M Shinoda, S Hatooka, M Suyama, T Mitsudomi, Y Yatabe, ... Kyobu geka. The Japanese Journal of Thoracic Surgery 50 (7), 602-605, 1997 | 7 | 1997 |
| A case of late-onset bleeding from an intercostal artery pseudoaneurysm after hemostasis using soft coagulation R Shimizu, K Suda, T Takemoto, S Fukuda, M Chiba, M Shimoji, J Soh, ... Surgical Case Reports 10 (1), 49, 2024 | | 2024 |
Y. YATABE在 ncc.go.jp 的电子邮件经过验证
